PTCT
PTC THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$68.97
+1.25%Margins
Gross margin
92.4%
EBITDA margin
15.1%
EBIT margin
12.0%
Net margin
-9.2%
FCF margin
-3.3%
55.4%
Return on equity
-3.3%
Return on assets
31.1%
Return on invested capital
0.36x
Asset turnover
$10.5M
Cash from operations
$25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026